从肝脾肾论证治疗早期糖尿病视网膜病变.pdfVIP

-60- Clinical Journal of Chinese Medicine 2014 Vol.(6) No.25 从肝脾肾论证治疗早期糖尿病视网膜病变 Treating early diabetic retinopathy based on the theory of Gan, Pi and Shen 吴学志 （驻马店市中心医院，河南 驻马店，463000 ） 中图分类号：R587.1 文献标识码：A 文章编号：1674-7860 （2014 ）25-0060-02 证型：DGB 【摘 要】 目的：观察从肝脾肾论证治疗糖尿病性视网膜病变的疗效。方法：选取2010 年 12 月-2012 年 12 月在本院内分 泌科确诊的糖尿病患者50 例，根据眼底镜检查确诊后随机分为两组，观察组25 例48 眼，对照组25 例47 眼，对照组给予控制血 糖，血压，血脂等常规治疗，必要时给予视网膜光凝。观察组在对照组基础上口服中药。结果：观察组临床疗效优于对照组，两 组比较差异有统计学意义（P0.05 ）。结论：通过从肝脾肾论证并结合中药治疗可以降低、延缓糖尿病视网膜病变的发生发展，并 最终减少致盲率。 【关键词】肝脾肾论证；中医药治疗；糖尿病视网膜病变；疗效观察 【Abstract 】 Objective: To observe clinical efficacy on treating early diabetic retinopathy based on the theory of Gan, Pi and Shen. Methods: 50 patients were randomly divided into the observation group and the control group from Dec. 2010 to Dec. 2012. 25 cases in the control group with 47 eyes were given blood glucose, blood pressure, blood lipids conventional treatment and panretinal photocoagulation as occasion requires. 25 cases in another group were given TCM medicine more. Clinical efficacy, plasma viscosity and adverse reaction in two groups were compared. Results: Clinical efficacy in the treatment group was better than that in the control group. The difference was statistically significant (P0.05). Conclusion: TCM medicine following the theory of Gan, Pi and Shen can control the disease development of diabetic retinopathy and reduce occoecation rate. 【Keywords 】 The Gan, Pi and Shen theory; TCM treatment; Diabetic retinopathy; Efficacy observation doi:10.3969/j.issn.1674-7860.2014.25.035 糖尿病视网膜病变是糖尿病常见且严重的微血管并发症 2 治疗方法 之一，以视网膜血管损害为最显著的特征。随着现代生活节奏 2.1 对照组 的加快，饮食不规律，缺乏相应的体育锻炼，糖尿病患者有增 所选病例均严格执行糖尿病饮食标准，给予常规西医治 多趋势，其对眼部危害所引起严重并发症得到越来越多的关 疗，包括营养神经、改善微循环、同时应用胰岛素或降糖药控 注。糖尿病视网膜病变已成为第